Highest-materiality recent filing
Celanese Q1 adj EPS $0.85, raises FY FCF outlook to $700-800M; Q2 guide $2.00-2.40
Q1 GAAP diluted EPS $0.41, adjusted EPS $0.85; net sales $2.3B, up 6% sequentially.
Full year 2025: GAAP diluted loss per share $10.44; adjusted EPS $3.98 (down from $8.18 in 2024); net sales $9.5B, down 7% YoY.
Celanese issues $600M 7.000% notes due 2031 and $800M 7.375% notes due 2034
Celanese US Holdings LLC issued $600M of 7.000% Senior Notes due 2031 and $800M of 7.375% Senior Notes due 2034.
Celanese Q3 GAAP loss $12.39/share; adj EPS $1.34, net sales $2.4B
GAAP diluted loss per share ($12.39) vs adj EPS $1.34; net loss $1.35B on $2.4B revenue.
Celanese to close Lanaken acetate tow facility by H2 2026; expects $70-90M in exit costs
Intends to cease manufacturing at Lanaken, Belgium acetate tow site by H2 2026, subject to works council consultation.
Celanese to sell Micromax portfolio to Element Solutions for ~$500M
Purchase price of approximately $500 million in cash, subject to adjustments; proceeds dedicated to deleveraging.
Celanese Q2 2025 GAAP EPS $1.90, adjusted EPS $1.44; guides Q3 adj. EPS $1.10-$1.40
Net sales $2.5B (+6% QoQ); operating profit $233M; adjusted EBIT $344M; operating EBITDA $532M.
Celanese Q1 GAAP loss $0.15, adj EPS $0.57; guides Q2 adj EPS $1.30-$1.50
Q1 GAAP diluted loss $0.15/sh; adjusted EPS $0.57; net sales $2.4B (+1% QoQ, -8% YoY).
Celanese upsizes tender offers; accepts all €552M EUR notes and $500M USD notes at premium
€552M of 4.777% EUR notes and $1.35B of 6.415% USD notes tendered; $500M USD notes accepted at 36.4% proration.
Celanese US issues $2.5B+ in senior notes; uses proceeds for tender offers and debt repayment
Issued $700M 6.500% notes due 2030, $1.1B 6.750% notes due 2033, and €750M 5.000% notes due 2031.
Celanese issues $1.8B of USD notes and €750M of Euro notes due 2030-2033
$700M of 6.500% Senior Notes due 2030 and $1.1B of 6.750% Senior Notes due 2033 issued.
Temporary waiver of mandatory prepayment for first $1.6B of unsecured note proceeds issued by June 30, 2025; further relief for amounts over $2.0B.
Celanese reports FY2024 GAAP loss of $13.86/sh; adjusted EPS $8.37; Q4 sales down 10% sequentially
Full-year 2024 GAAP diluted loss per share of $13.86; adjusted EPS $8.37; net sales $10.3B, down 6% YoY.
Celanese appoints Todd Elliott as SVP Engineered Materials, succeeding Tom Kelly
Todd Elliott, former SVP of Acetyls who retired in 2020, rejoins Celanese to lead Engineered Materials effective Feb 3, 2025.
Celanese appoints Scott Richardson CEO, Edward Galante Chair as of Jan 1, 2025
Scott Richardson named CEO and President, succeeding Lori Ryerkerk who steps down from Board and roles.
Celanese enters $1B term loan facility and amends leverage covenants
New $1.0B delayed-draw term loan facility due 364 days from borrowing, available through March 15, 2025.
Celanese Q3 GAAP EPS $1.08, adj EPS $2.44; cuts dividend ~95%, Q4 adj EPS guidance ~$1.25
Q3 GAAP diluted EPS $1.08; adjusted EPS $2.44; net sales $2.6B, down slightly YoY.
Q2 adjusted EPS $2.38, sales $2.65B; guides Q3 $2.75-3.00, FY $10.25-10.75
GAAP diluted EPS $1.42 vs $2.00 YoY; adjusted EPS $2.38 vs $2.17 YoY.
Celanese Q1 GAAP EPS $1.10, adjusted EPS $2.08; guides Q2 $2.60-$3.00
Q1 net sales $2.6B, up 2% sequentially; GAAP diluted EPS $1.10, adjusted EPS $2.08.
On February 13, 2025, the Board of Directors (the “Board”) of Celanese Corporation (the “Company”) increased the size of the Board from 12 to 13 members and elected Scott Sutton as a director of the Company, in each case effective March 1, 2025.
On January 14, 2024, Celanese Corporation (the “Company”) appointed Todd Elliott as Senior Vice President, Engineered Materials, effective as of February 3, 2025, to succeed Thomas Kelly
Thomas Kelly, who is stepping down on January 31, 2025 and will serve in a transition role through March 10, 2025.
Max materiality 0.85 · Median 0.53 · Most common event earnings